Menu Search

International Biotechnology Trust

IBT:LSE

International Biotechnology Trust

Actions
  • Price (GBX)718.22
  • Today's Change2.22 / 0.31%
  • Shares traded12.85k
  • 1 Year change+26.89%
  • Beta0.1721
Data delayed at least 20 minutes, as of Nov 14 2024 12:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year International Biotechnology Trust grew revenues 269.31% from 12.06m to 44.54m while net income improved 470.62% from 6.81m to 38.88m.
Gross margin90.12%
Net profit margin87.29%
Operating margin87.59%
Return on assets12.68%
Return on equity14.07%
Return on investment14.07%
More ▼

Cash flow in GBPView more

Cash flow information is not available for International Biotechnology Trust.
Cash flow per share--
Price/Cash flow per share--
Book value per share7.66
Tangible book value per share7.66
More ▼

Balance sheet in GBPView more

International Biotechnology Trust has a Debt to Total Capital ratio of 7.48%.
Current ratio0.4113
Quick ratio--
Total debt/total equity0.0809
Total debt/total capital0.0748
More ▼

Growth rates in GBP

Year on year, growth in dividends per share fell -48.40% while earnings per share excluding extraordinary items rose 506.46%. Additionally, five year annualized dividend per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)3.75%
Div growth rate (5 year)-11.29%
Payout ratio (TTM)27.70%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		514.34
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.